Oropharynx cancer
Drug research and approvals for oropharynx cancer: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 22, 2026, 141 studies of oropharynx cancer are recruiting on ClinicalTrials.gov, and Health Canada has authorized 7 drug trials for it since 2013.
- Recruiting worldwide: 141
- Trials authorized in Canada: 7
- FDA orphan approvals: 0
- EU medicines: 0
- Characterisation of Immunological and Molecular Changes Evolving in Patients Undergoing Radiotherapy (CHIMERA)NCT07938385 · Not reported · Royal Marsden NHS Foundation Trust · starts May 20, 2022
- TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell CarcinomaNCT07898124 · Phase 1 · Metaclipse Therapeutics Corporation · starts Oct 1, 2026
- Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck CancersNCT07857655 · Phase 4 · OHSU Knight Cancer Institute · starts Sep 22, 2026
- A Study Evaluating Ficerafusp Alfa (BCA101) QW in Combination With Pembrolizumab vs Alternative Ficerafusp Alfa Dosing…NCT07807163 · Phase 2 · Bicara Therapeutics · starts Sep 1, 2026
- Scheduled IV Fluids in the Supportive Management of Patients Undergoing Chemo-radiotherapy for Head and Neck CancerNCT07784855 · Not applicable · West Virginia University · starts Nov 1, 2026
- A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell…NCT07768189 · Phase 3 · Corbus Pharmaceuticals Inc. · starts Sep 29, 2026
- HPV-associated Oropharyngeal Carcinoma (HPV-OPC)NCT07718620 · Not applicable · Masaryk Memorial Cancer Institute · starts May 25, 2026
- Brief Clinical Psychological Intervention With Biofeedback in Head and Neck CancerNCT07712120 · Not applicable · University of Turin, Italy · starts Nov 20, 2025
- Thermotherapy for Head and Neck Cancer PatientsNCT07690618 · Phase 1 · Erasmus Medical Center · starts Sep 1, 2026
How its trials ended
333 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 82 whose ending is known, 22% met their primary endpoint, 6% missed it and 72% stopped early.
- Ongoing11835%
- Completed, result not reported11234%
- Stopped: other or unclear319%
- Status unknown216%
- Met its primary endpoint185%
- Stopped: enrollment or feasibility144%
- Stopped: sponsor or business decision62%
- Missed its primary endpoint52%
- Stopped: funding41%
- Stopped: lack of efficacy31%
- Stopped: safety1<1%
| Aug 3, 2022 | Spect-ct guided elective contralateral neck treatment (SELECT) for patients with lateralized oropharyngeal cancer: a phase III randomized controlled trialTechnetium tc 99M tsc / Technelite / Ultra-technekow | Canadian Cancer Trials Group, Cancer Research Institute, Queen's University | Ongoing |
| Aug 5, 2021 | A randomized phase II/III trial of deintensified radiation therapy for patients with early-stage, P16-positive, non-smoking associated oropharyngeal cancerOpdivo | Nrg Oncology | Closed |
| Jan 13, 2021 | A feasibility trial of lymphatic mapping with spect-ct for evaluating contralateral disease in lateralized oropharynx cancer using 99m-technetium sulfur colloidTechnetium tc 99M sulfur colloid | University Health Network | Ongoing |
| Jul 23, 2018 | Induction chemotherapy followed by transoral robotic surgery and neck dissection for definitive management of oropharyngeal squamous cell carcinomaDocetaxel/ Cisplatin/ Carboplatin | McGill University Health Centre | Ongoing |
| Jan 5, 2018 | Randomized phase II study of cisplatin plus radiotherapy versus durvalumab plus radiotherapy followed by adjuvant durvalumab versus durvalumab plus…Durvalumab / Tremelimumab | Canadian Cancer Trials Group, Cancer Research Institute, Queen's University | Closed |
| Nov 18, 2014 | A randomized phase II trial for patients with P16 positive, non-smoking associated, locoregionally advanced oropharyngeal cancerCisplatin | Nrg Oncology | Closed |
| Oct 31, 2013 | Randomized phase II trial of transoral endoscopic head and neck surgery followed by risk-based imrt and weekly cisplatin versus imrt and weekly cisplatin for…Cisplatin | American College of Radiology Radiation Therapy Oncology Group | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA